Purchases and Sales Made in Q3 2022 in Anika Therapeutics, Inc. (ANIK)
This table provides information about the institutional ownership of Anika Therapeutics, Inc. (ANIK) during Q3 2022. The information is specifically focused on institutions that hold shares of Anika Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-69.6K- 10.16% |
$1.51M - $1.72M
|
615K
$15.1M
|
|
|
Nov 10, 2022
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-79.7K- 53.94% |
$1.73M - $1.97M
|
68K
$1.67M
|
|
|
May 14, 2024
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-79.7K- 53.94% |
$1.73M - $1.97M
|
68K
$1.67M
|
|
|
Nov 14, 2022
Q3 2022
|
Kayne Anderson Rudnick Investment Management LLC
Los Angeles, CA |
SELL
|
- |
-109KClosed |
$2.37M - $2.69M
|
0
$0
|
|
|
Oct 26, 2022
Q3 2022
|
Fort Washington Investment Advisors Inc
|
SELL
|
- |
-109K- 22.19% |
$2.38M - $2.7M
|
384K
$9.41M
|
|
|
Oct 31, 2022
Q3 2022
|
Capital Management Corp
|
SELL
|
- |
-173K- 62.78% |
$3.76M - $4.26M
|
102K
$2.51M
|